Issued Patents All Time
Showing 1–25 of 95 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12359201 | 17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof | Frederic Tremblay, Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng +6 more | 2025-07-15 |
| 12338439 | Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof | Akin Akinc, Martin Maier, James Butler, Jingxuan Liu | 2025-06-24 |
| 12227744 | Compositions and methods for inhibiting expression of transthyretin | Dinah Wen-Yee Sah, Rene Alvarez, Stuart Milstein, Qingmin Chen | 2025-02-18 |
| 12091666 | Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof | Kevin Fitzgerald, Timothy Ryan Mooney | 2024-09-17 |
| 12091661 | Organic compositions to treat HSF1-related diseases | Satyanarayana Kuchimanchi, Stuart Milstein, Markus Warmuth, Wenlai Zhou, Ping Zhu +1 more | 2024-09-17 |
| 12071619 | SERPINA1 iRNA compositions and methods of use thereof | Alfica Sehgal, Klaus Charisse, Brian Bettencourt, Martin Maier, Kallanthottathil G. Rajeev +1 more | 2024-08-27 |
| 12031133 | GNAQ targeted dsRNA compositions and methods for inhibiting expression | Jared Gollob, Ivanka Toudjarska, David Bumcrot | 2024-07-09 |
| 11987792 | Compositions and methods for inhibiting expression of the LECT2 gene | Huilei Xu | 2024-05-21 |
| 11884919 | Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene | Antonin de Fougerolles, Tatiana Novobrantseva | 2024-01-30 |
| 11866701 | Complement component C3 iRNA compositions and methods of use thereof | Anna Borodovsky | 2024-01-09 |
| 11859185 | Glucokinase (GCK) iRNA compositions and methods of use thereof | Kevin Fitzgerald, David V. Erbe | 2024-01-02 |
| 11834661 | Angiotensinogen (AGT) iRNA compositions and methods of use thereof | Donald C. Foster, Mark K. Schlegel | 2023-12-05 |
| 11685918 | Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof | — | 2023-06-27 |
| 11434487 | Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof | Kevin Fitzgerald, Huilei Xu | 2022-09-06 |
| 11419942 | Angiotensinogen (AGT) iRNA compositions and methods of use thereof | Donald C. Foster, Brian Bettencourt, Klaus Charisse, Satyanarayana Kuchimanchi, Martin Maier +1 more | 2022-08-23 |
| 11408001 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | Kevin Fitzgerald, William Querbes, James Butler, Stephanie Williams, Abigail Liebow +4 more | 2022-08-09 |
| 11319539 | Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof | Kevin Fitzgerald, Timothy Ryan Mooney | 2022-05-03 |
| 11229663 | Serum amyloid P component (APCS) iRNA compositions and methods of use thereof | Kevin Fitzgerald | 2022-01-25 |
| 11198872 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | William Querbes, Kevin Fitzgerald, James Butler, Stephanie Williams, Martin Maier | 2021-12-14 |
| 11180757 | 17β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof | Frederic Tremblay, Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng +6 more | 2021-11-23 |
| 11149273 | Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene | Antonin de Fougerolles, Tatiana Novobrantseva | 2021-10-19 |
| 11142766 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | Kevin Fitzgerald, William Querbes, James Butler, Stephanie Williams, Abigail Liebow +4 more | 2021-10-12 |
| 11136582 | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | Kevin Fitzgerald, Brian Bettencourt, Jennifer Willoughby | 2021-10-05 |
| 11091761 | Organic compositions to treat HSF1-related diseases | Satyanarayana Kuchimanchi, Stuart Milstein, Markus Warmuth, Wenlai Zhou, Ping Zhu +1 more | 2021-08-17 |
| 11066670 | Insulin-like growth factor binding protein, acid labile subunit (IGFALS) and insulin-like growth factor 1 (IGF-1) iRNA compositions and methods of use thereof | James Butler, Kevin Fitzgerald, Brian Bettencourt, Huilei Xu | 2021-07-20 |